BTAI
BioXcel Therapeutics, Inc.
+0.02 (+49.66%)0.07USD1.1M成交股數2.1M市值–本益比(近四季)2.8股價營收比+51.7%營收年增(近四季)–下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0 · 43K |
| 近 180 天 淨額 | −43K |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-15 | 06-17 | Steinhart Richard I | Chief Financial Officer | M 選擇權執行 | 35 | – | – | 26.3K | SEC |
| 2026-06-15 | 06-17 | Mehta Vimal | CEO and President | M 選擇權執行 | 219 | – | – | 69.8K | SEC |
| 2026-06-15 | 06-17 | Rodriguez Javier | See Remarks | M 選擇權執行 | 35 | – | – | 26.8K | SEC |
| 2026-06-15 | 06-17 | Yocca Frank | Chief Scientific Officer | M 選擇權執行 | 35 | – | – | 26.2K | SEC |
| 2026-05-20 | 05-22 | Rodriguez Javier | See Remarks | S 公開市場賣出(10b5-1) | 6.6K | 1.08 | 7K | 26.8K | SEC |
| 2026-05-20 | 05-22 | Mehta Vimal | CEO and President | S 公開市場賣出(10b5-1) | 19.4K | 1.09 | 21K | 69.6K | SEC |
| 2026-05-20 | 05-22 | Steinhart Richard I | Chief Financial Officer | S 公開市場賣出(10b5-1) | 6.8K | 1.09 | 7K | 26.3K | SEC |
| 2026-05-20 | 05-22 | Yocca Frank | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 6.8K | 1.09 | 7K | 26.2K | SEC |
| 2026-05-04 | 05-22 | Mehta Vimal | CEO and President | M 選擇權執行 | 49.8K | – | – | 89.0K | SEC |
| 2026-05-04 | 05-22 | Steinhart Richard I | Chief Financial Officer | M 選擇權執行 | 17.5K | – | – | 33.1K | SEC |
| 2026-05-04 | 05-22 | Yocca Frank | Chief Scientific Officer | M 選擇權執行 | 17.5K | – | – | 33.0K | SEC |
| 2026-05-04 | 05-22 | Rodriguez Javier | See Remarks | M 選擇權執行 | 17.5K | – | – | 33.4K | SEC |
| 2026-05-01 | 05-07 | Yocca Frank | Chief Scientific Officer | M 選擇權執行 | 9.0K | – | – | 15.5K | SEC |
| 2026-05-01 | 05-07 | Mehta Vimal | CEO and President | M 選擇權執行 | 18.0K | – | – | 39.3K | SEC |
| 2026-05-01 | 05-07 | Rodriguez Javier | See Remarks | M 選擇權執行 | 9.0K | – | – | 15.9K | SEC |
| 2026-05-01 | 05-07 | Steinhart Richard I | Chief Financial Officer | M 選擇權執行 | 9.0K | – | – | 15.6K | SEC |
| 2026-03-15 | 03-16 | Mehta Vimal | CEO and President | M 選擇權執行 | 219 | – | – | 21.3K | SEC |
| 2026-03-15 | 03-16 | Steinhart Richard I | Chief Financial Officer | M 選擇權執行 | 35 | – | – | 6.6K | SEC |
| 2026-03-15 | 03-16 | Rodriguez Javier | See Remarks | M 選擇權執行 | 35 | – | – | 6.9K | SEC |
| 2026-03-15 | 03-16 | Yocca Frank | Chief Scientific Officer | M 選擇權執行 | 35 | – | – | 6.5K | SEC |
| 2026-03-14 | 03-16 | Yocca Frank | Chief Scientific Officer | M 選擇權執行 | 33 | – | – | 6.5K | SEC |
| 2026-03-14 | 03-16 | Mehta Vimal | CEO and President | M 選擇權執行 | 164 | – | – | 21.0K | SEC |
| 2026-03-14 | 03-16 | Steinhart Richard I | Chief Financial Officer | M 選擇權執行 | 33 | – | – | 6.6K | SEC |
| 2026-03-14 | 03-16 | Rodriguez Javier | See Remarks | M 選擇權執行 | 33 | – | – | 6.8K | SEC |
| 2025-12-15 | 12-15 | Steinhart Richard I | Chief Financial Officer | M 選擇權執行 | 35 | – | – | 6.6K | SEC |
| 2025-12-15 | 12-15 | Rodriguez Javier | See Remarks | M 選擇權執行 | 35 | – | – | 6.8K | SEC |
| 2025-12-15 | 12-15 | Yocca Frank | Chief Scientific Officer | M 選擇權執行 | 35 | – | – | 6.5K | SEC |
| 2025-12-15 | 12-15 | Mehta Vimal | CEO and President | M 選擇權執行 | 219 | – | – | 20.9K | SEC |
| 2025-12-14 | 12-15 | Mehta Vimal | CEO and President | M 選擇權執行 | 164 | – | – | 20.7K | SEC |
| 2025-12-14 | 12-15 | Steinhart Richard I | Chief Financial Officer | M 選擇權執行 | 33 | – | – | 6.5K | SEC |
| 2025-12-14 | 12-15 | Rodriguez Javier | See Remarks | M 選擇權執行 | 33 | – | – | 6.8K | SEC |
| 2025-12-14 | 12-15 | Yocca Frank | Chief Scientific Officer | M 選擇權執行 | 33 | – | – | 6.4K | SEC |
| 2025-10-31 | 11-03 | MACK DAVID J. | Director | M 選擇權執行 | 1.7K | – | – | 20.3K | SEC |
| 2025-09-30 | 10-01 | MACK DAVID J. | Director | M 選擇權執行 | 1.7K | – | – | 18.6K | SEC |
| 2025-09-15 | 09-16 | Mehta Vimal | CEO and President | M 選擇權執行 | 219 | – | – | 20.5K | SEC |
| 2025-09-15 | 09-16 | Steinhart Richard I | Chief Financial Officer | M 選擇權執行 | 35 | – | – | 6.5K | SEC |
| 2025-09-15 | 09-16 | Rodriguez Javier | See Remarks | M 選擇權執行 | 35 | – | – | 6.7K | SEC |
| 2025-09-15 | 09-16 | Yocca Frank | Chief Scientific Officer | M 選擇權執行 | 35 | – | – | 6.4K | SEC |
| 2025-09-14 | 09-16 | Yocca Frank | Chief Scientific Officer | M 選擇權執行 | 33 | – | – | 6.3K | SEC |
| 2025-09-14 | 09-16 | Rodriguez Javier | See Remarks | M 選擇權執行 | 33 | – | – | 6.7K | SEC |
| 2025-09-14 | 09-16 | Mehta Vimal | CEO and President | M 選擇權執行 | 163 | – | – | 20.3K | SEC |
| 2025-09-14 | 09-16 | Steinhart Richard I | Chief Financial Officer | M 選擇權執行 | 33 | – | – | 6.5K | SEC |
| 2025-08-31 | 09-02 | MACK DAVID J. | Director | M 選擇權執行 | 1.7K | – | – | 16.9K | SEC |
| 2025-07-31 | 07-31 | MACK DAVID J. | Director | M 選擇權執行 | 1.7K | – | – | 15.2K | SEC |
| 2025-07-22 | 07-22 | Rodriguez Javier | See Remarks | M 選擇權執行 | 625 | – | – | 6.7K | SEC |
| 2025-07-22 | 07-22 | Steinhart Richard I | Chief Financial Officer | M 選擇權執行 | 625 | – | – | 6.4K | SEC |
| 2025-07-22 | 07-22 | Mehta Vimal | CEO and President | A 獲配股票 | 15.6K | – | – | 20.1K | SEC |
| 2025-07-22 | 07-22 | Yocca Frank | Chief Scientific Officer | A 獲配股票 | 4.4K | – | – | 6.3K | SEC |
| 2025-07-22 | 07-22 | Steinhart Richard I | Chief Financial Officer | A 獲配股票 | 4.4K | – | – | 5.8K | SEC |
| 2025-07-22 | 07-22 | Rodriguez Javier | See Remarks | A 獲配股票 | 4.4K | – | – | 6.0K | SEC |
| 2025-06-30 | 06-30 | MACK DAVID J. | Director | M 選擇權執行 | 1.7K | – | – | 13.5K | SEC |
| 2025-06-15 | 06-16 | Steinhart Richard I | Chief Financial Officer | M 選擇權執行 | 35 | – | – | 1.4K | SEC |
| 2025-06-15 | 06-16 | Yocca Frank | Chief Scientific Officer | M 選擇權執行 | 35 | – | – | 1.9K | SEC |
| 2025-06-15 | 06-16 | Mehta Vimal | CEO and President | M 選擇權執行 | 219 | – | – | 4.5K | SEC |
| 2025-06-15 | 06-16 | Rodriguez Javier | See Remarks | M 選擇權執行 | 35 | – | – | 1.7K | SEC |
| 2025-06-14 | 06-16 | Rodriguez Javier | See Remarks | M 選擇權執行 | 33 | – | – | 1.6K | SEC |
| 2025-06-14 | 06-16 | Yocca Frank | Chief Scientific Officer | M 選擇權執行 | 33 | – | – | 1.9K | SEC |
| 2025-06-14 | 06-16 | Mehta Vimal | CEO and President | M 選擇權執行 | 163 | – | – | 4.3K | SEC |
| 2025-06-14 | 06-16 | Steinhart Richard I | Chief Financial Officer | M 選擇權執行 | 33 | – | – | 1.4K | SEC |
| 2025-05-31 | 06-02 | MACK DAVID J. | Director | M 選擇權執行 | 1.7K | – | – | 11.9K | SEC |
| 2025-04-30 | 05-01 | MACK DAVID J. | Director | M 選擇權執行 | 1.7K | – | – | 10.2K | SEC |
| 2025-03-31 | 04-01 | MACK DAVID J. | Director | M 選擇權執行 | 1.7K | – | – | 8.5K | SEC |
| 2025-03-15 | 03-17 | Steinhart Richard I | Chief Financial Officer | M 選擇權執行 | 34 | – | – | 1.4K | SEC |
| 2025-03-15 | 03-17 | Mehta Vimal | CEO and President | M 選擇權執行 | 217 | – | – | 4.1K | SEC |
| 2025-03-15 | 03-17 | Rodriguez Javier | See Remarks | M 選擇權執行 | 34 | – | – | 1.6K | SEC |
| 2025-03-15 | 03-17 | Yocca Frank | Chief Scientific Officer | M 選擇權執行 | 34 | – | – | 1.9K | SEC |
| 2025-03-14 | 03-17 | Mehta Vimal | CEO and President | M 選擇權執行 | 162 | – | – | 3.9K | SEC |
| 2025-03-14 | 03-17 | Yocca Frank | Chief Scientific Officer | M 選擇權執行 | 31 | – | – | 1.8K | SEC |
| 2025-03-14 | 03-17 | Steinhart Richard I | Chief Financial Officer | M 選擇權執行 | 31 | – | – | 1.3K | SEC |
| 2025-03-14 | 03-17 | Rodriguez Javier | See Remarks | M 選擇權執行 | 31 | – | – | 1.6K | SEC |
| 2025-02-28 | 03-04 | MACK DAVID J. | Director | M 選擇權執行 | 1.7K | – | – | 6.8K | SEC |
| 2025-01-31 | 02-04 | MACK DAVID J. | Director | M 選擇權執行 | 27.1K | – | – | 81.3K | SEC |
| 2024-12-31 | 01-03 | MACK DAVID J. | Director | M 選擇權執行 | 27.1K | – | – | 54.2K | SEC |
| 2024-12-16 | 12-17 | Rodriguez Javier | See Remarks | S 公開市場賣出(10b5-1) | 210 | 0.36 | 75.60 | 24.6K | SEC |
| 2024-12-16 | 12-17 | Yocca Frank | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 225 | 0.35 | 78.75 | 28.9K | SEC |
| 2024-12-16 | 12-17 | Yocca Frank | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 205 | 0.36 | 73.80 | 29.2K | SEC |
| 2024-12-16 | 12-17 | Rodriguez Javier | See Remarks | S 公開市場賣出(10b5-1) | 220 | 0.36 | 79.20 | 24.4K | SEC |
| 2024-12-16 | 12-17 | Steinhart Richard I | Chief Financial Officer | S 公開市場賣出(10b5-1) | 205 | 0.36 | 73.80 | 21.2K | SEC |
| 2024-12-16 | 12-17 | Steinhart Richard I | Chief Financial Officer | S 公開市場賣出(10b5-1) | 372 | 0.36 | 133.92 | 20.9K | SEC |
| 2024-12-16 | 12-17 | Mehta Vimal | CEO and President | S 公開市場賣出(10b5-1) | 983 | 0.36 | 353.88 | 60.9K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| 千禧 MILLENNIUM MANAGEMENT LLC | 2.1M | 3.0M | +178K (+9%) | 加碼 |
| 橡樹(馬克斯) OAKTREE CAPITAL MANAGEMENT LP | 1.4M | 1.9M | +1.1M (+472%) | 加碼 |
| VANGUARD CAPITAL MANAGEMENT LLC | 920K | 1.3M | +712K (+343%) | 加碼 |
| Oaktree Fund Advisors, LLC | 246K | 346K | +203K (+472%) | 加碼 |
| GEODE CAPITAL MANAGEMENT, LLC | 242K | 342K | +12.1K (+5%) | 加碼 |
| BlackRock, Inc. | 179K | 253K | +95.2K (+113%) | 加碼 |
| UBS Group AG | 158K | 223K | +105K (+199%) | 加碼 |
| 城堡 CITADEL ADVISORS LLC | 149K | 210K | 新進 | 新進 |
| VANGUARD FIDUCIARY TRUST CO | 137K | 193K | +52.0K (+61%) | 加碼 |
| STATE STREET CORP | 92.1K | 130K | 不變 | 持平 |
| FMR LLC | 90.3K | 127K | 不變 | 持平 |
| &PARTNERS | 83.6K | 118K | +2.7K (+3%) | 加碼 |
| JONES FINANCIAL COMPANIES LLLP | 63.1K | 83K | −68.7K (-52%) | 減碼 |
| NORTHERN TRUST CORP | 56.3K | 79K | +20.0K (+55%) | 加碼 |
| HighTower Advisors, LLC | 41.0K | 58K | 不變 | 持平 |
| Quadrature Capital Ltd | 38.0K | 54K | 新進 | 新進 |
| Headlands Technologies LLC | 25.6K | 36K | 新進 | 新進 |
| StoneX Group Inc. | 20.7K | 29K | 新進 | 新進 |
| Beacon Pointe Advisors, LLC | 18.8K | 27K | −40 (-0%) | 減碼 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 17.2K | 24K | 新進 | 新進 |
| Portfolio Strategies, Inc. | 16.8K | 24K | +4.7K (+38%) | 加碼 |
| OSAIC HOLDINGS, INC. | 16.2K | 23K | 不變 | 持平 |
| TWO SIGMA SECURITIES, LLC | 10.8K | 15K | 新進 | 新進 |
| DIVERSIFY WEALTH MANAGEMENT, LLC | 15.0K | 13K | 不變 | 持平 |
| Diversify Advisory Services, LLC | 15.0K | 13K | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 46 +6 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 10 / 4 / 11 / 6 |
| 機構合計持股 · 佔流通股 | 6.2M · 19.7% |
| 合計季末市值 | 8.7M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 6.1M |
|---|---|
| 與上期比 | +84.8% |
| 佔流通股數 | 19.56% |
| 日均成交量 | 7.2M |
| 回補天數 | 1.0 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 6.1M | +84.8% | 19.56% | 7.2M | 1.0 |
| 2026-08-14 | 3.3M | -21.4% | 10.59% | 797K | 4.2 |
| 2026-07-31 | 4.2M | +4.2% | 13.46% | 435K | 9.7 |
| 2026-07-15 | 4.0M | +10.4% | 12.92% | 2.5M | 1.6 |
| 2026-06-30 | 3.7M | -15.1% | 11.70% | 619K | 5.9 |
| 2026-06-15 | 4.3M | +22.4% | 13.78% | 630K | 6.9 |
| 2026-05-29 | 3.5M | -0.8% | 11.26% | 788K | 4.5 |
| 2026-05-15 | 3.6M | -16.2% | 11.36% | 628K | 5.7 |
| 2026-04-30 | 4.2M | +7.5% | 13.55% | 888K | 4.8 |
| 2026-04-15 | 3.9M | +19.2% | 12.61% | 1.3M | 3.1 |
| 2026-03-31 | 3.3M | +18.1% | 10.58% | 724K | 4.6 |
| 2026-03-13 | 2.8M | +49.5% | 8.96% | 5.4M | 1.0 |
| 2026-02-27 | 1.9M | -3.2% | 5.99% | 252K | 7.5 |
| 2026-02-13 | 1.9M | +26.9% | 6.19% | 345K | 5.6 |
| 2026-01-30 | 1.5M | +11.8% | 4.88% | 563K | 2.7 |
| 2026-01-15 | 1.4M | +32.6% | 4.36% | 715K | 1.9 |
| 2025-12-31 | 1.0M | +5.2% | 3.29% | 460K | 2.2 |
| 2025-12-15 | 980K | +7.7% | 3.13% | 478K | 2.1 |
| 2025-11-28 | 910K | -42.5% | 2.91% | 681K | 1.3 |
| 2025-11-14 | 1.6M | +12.7% | 5.05% | 714K | 2.2 |
| 2025-10-31 | 1.4M | +22.9% | 4.48% | 788K | 1.8 |
| 2025-10-15 | 1.1M | -28.2% | 3.64% | 1.2M | 1.0 |
| 2025-09-30 | 1.6M | +10.2% | 5.08% | 1.4M | 1.1 |
| 2025-09-15 | 1.4M | -64.3% | 4.61% | 2.7M | 1.0 |
| 2025-08-29 | 4.0M | +166.7% | 12.92% | 11.6M | 1.0 |
| 2025-08-15 | 1.5M | +471.4% | 4.85% | 40.8M | 1.0 |